Healthcare / Medical Instruments & SuppliesUpdated 2026-05-10 22:07 UTC

TPEX/1565 stock hub

TPEX/1565 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

TPEX/1565is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

5.2B

Taipei Exchange

Market data

Live price

Current market quote for this ticker.

Current price

TPEX/1565

In the news

Latest news · TPEX/1565

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12P50 15.5P75 22.5

Trailing P/E15.8

P25 14.4P50 18P75 31.9

ROE5.6

P25 -16.2P50 0.3P75 9.8

ROIC9.1

P25 -11.7P50 -0.2P75 8.8

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All TPEX/1565 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

240

Groups with data

Currency

TWD

Showing 240 of 240 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Taiwan
Country code	TW
Employees	3,698
Employees Change	-214%
Employees Change Percent	-5.47
Enterprise value	TWD 3.3B
Exchange	Taipei Exchange
Financial currency	TWD
First seen	2026-05-10
Industry	Medical Instruments & Supplies
Isin	TW0001565000
Last refreshed	2026-05-10
Market cap	TWD 5.2B
Price	TWD 103
Price currency	TWD
Rev Per Employee	1,056,090.05x
Sector	Healthcare
Sic	3851
Symbol	tpex/1565
Website	https://www.stshine.com.tw

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	6.81%
EV Earnings	9.5x
EV/EBIT	7.46x
EV/EBITDA	4.96x
EV/FCF	11.9x
EV/Sales	0.86x
FCF yield	5.44%
P/B ratio	0.82x
P/E ratio	15.78x
P/S ratio	1.32x
PE Ratio10 Y	17.37x
PE Ratio3 Y	14.67x
PE Ratio5 Y	15.23x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	11.28%
EBITDA Margin	16.18%
FCF margin	7.2%
Gross margin	22.16%
Gross Profit	TWD 865.5M
Gross Profit Growth	-21.79%
Gross Profit Growth Q	-50.34%
Gross Profit Growth3 Y	-13.64%
Gross Profit Growth5 Y	-7.1%
Net Income	TWD 352.1M
Net Income Growth	-39.11%
Net Income Growth Q	-47.92%
Net Income Growth Years	0%
Net Income Growth3 Y	-23.57%
Net Income Growth5 Y	-9.39%
Pretax Margin	11.49%
Profit Margin	9.02%
Profit Per Employee	TWD 95,225
Profitable Years	7
ROA	3.51
Roa5y	6.49
ROCE	6.78
ROE	5.6
Roe5y	12.1
ROIC	9.09
Roic5y	14.49

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-11.88%
Cagr15y	-4.51%
Cagr1y	-35.5%
Cagr20y	5.07%
Cagr3y	-20.95%
Cagr5y	-15.47%
Div CAGR10	-8.79%
Div CAGR3	-14.12%
Div CAGR5	-12%
EPS Growth	-39.39
EPS Growth Q	-48.6
EPS Growth Years	0
EPS Growth3 Y	-23.69
EPS Growth5 Y	-9.5
FCF Growth	-40.68%
FCF Growth Q	-17.87%
FCF Growth3 Y	-23.74%
FCF Growth5 Y	-8.7%
OCF Growth	-38.03%
OCF Growth Q	-15.66%
OCF Growth10 Y	-11.42%
OCF Growth3 Y	-22.82%
OCF Growth5 Y	-6.9%
Revenue Growth	-9.52x
Revenue Growth Q	-23.37x
Revenue Growth Years	0x
Revenue Growth3 Y	-6.29x
Revenue Growth5 Y	-3.84x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	TWD 0.5
Assets	TWD 7.6B
Cash	TWD 2.1B
Current Assets	TWD 4.1B
Current Liabilities	TWD 1.1B
Debt	TWD 269.2M
Debt EBITDA	TWD 0.4
Debt Equity	TWD 0.04
Debt FCF	TWD 0.96
Equity	TWD 6.3B
Interest Coverage	63.49
Liabilities	TWD 1.3B
Long Term Assets	TWD 3.5B
Long Term Liabilities	TWD 230.7M
Net Cash	TWD 1.8B
Net Cash By Market Cap	TWD 35.27
Net Cash Growth	-0.6%
Net Debt EBITDA	TWD -2.88
Net Debt Equity	TWD -0.29
Net Debt FCF	TWD -6.48
Tangible Book Value	TWD 6.3B
Tangible Book Value Per Share	TWD 90.03
WACC	5.95

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	3.53
Inventory Turnover	2.67
Net Working Capital	TWD 885.9M
Quick ratio	2.4
Working Capital	TWD 2.8B
Working Capital Turnover	TWD 1.29

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.39%
Dividend Growth	35.71%
Dividend Growth Years	1%
Dividend per share	TWD 5.8
Dividend Years	22
Dividend Yield	5.66%
Ex Div Date	2025-08-25
Last Dividend	TWD 9.5
Payout Frequency	Annual
Payout Ratio	136.01%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-71.75%
1Y total return	-35.48%
200-day SMA	127
3Y total return	-50.61%
50-day SMA	105.7
50-day SMA vs 200-day SMA	50under200
5Y total return	-56.83%
All Time High	1,025
All Time High Change	-90%
All Time High Date	2017-12-21
All Time Low	8.24
All Time Low Change	1,144.23%
All Time Low Date	2003-07-29
ATR	1.91
Beta	0.35
Beta1y	0.31
Beta2y	0.34
Ch YTD	-11.64
High	102.5
High52	176
High52 Date	2025-05-14
High52ch	-41.76%
Low	102
Low52	102
Low52 Date	2026-05-08
Low52ch	0.49%
Ma50ch	-3.02%
Price vs 200-day SMA	-19.28%
RSI	41.32
RSI Monthly	23.15
RSI Weekly	24.55
Sharpe ratio	-2.11x
Sortino ratio	-2.53
Total Return	5.27%
Tr YTD	-11.64
Tr15y	-49.98%
Tr1m	-0.49%
Tr3m	-10.09%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	TWD 440.6M
Operating Income Growth	-32.53
Operating Income Growth Q	-63.56
Operating Income Growth3 Y	-20.43
Operating Income Growth5 Y	-11.59
Operating margin	11.28

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	45,304,728%
Net Borrowing	-148,661,000
Shares Insiders	6.08%
Shares Institutions	13.46%
Shares Out	50,416,516
Shares Qo Q	2%
Shares Yo Y	0.39%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	TWD 281.1M
Average Volume	166,187.05x
Bv Per Share	90.09
CAPEX	TWD -70.6M
Ch10y	-82.72
Ch15y	-74.88
Ch1m	-0.49
Ch1y	-39.35
Ch20y	7.84
Ch3m	-10.09
Ch3y	-58.25
Ch5y	-66.67
Ch6m	-22.93
Change	-0.49%
Change From Open	0
Close	103
Days Gap	-0.49
Depreciation Amortization	195,163,000
Dollar Volume	17,730,757.5
Earnings Date	2026-05-13
EBIT	TWD 440.6M
EBITDA	TWD 632M
EPS	TWD 6.5
F Score	5
FCF	TWD 281.1M
FCF EV Yield	8.4x
FCF Per Share	TWD 5.58
Financing CF	-629,464,000
Fiscal Year End	December
Founded	1,981
Graham Number	114.74501
Graham Upside	11.95
Income Tax	TWD 96.4M
Investing CF	-54,243,000
Is Primary Listing	1
Last Earnings Date	2025-11-04
Last Report Date	2025-12-31
Last Split Date	2009-08-26
Last Split Type	Forward
Lynch Fair Value	TWD 32.48
Lynch Upside	-68.31
Ma150	118.3
Ma150ch	-13.34%
Ma20	104.6
Ma20ch	-1.96%
Net CF	-332,385,000
Next Earnings Date	2026-05-13
Open	102.5
P FCF Ratio	18.39
P OCF Ratio	14.69
Payment Date	2025-09-12
Position In Range	100
Ppne	3,405,359,000
Price Date	2026-05-08
Price EBITDA	TWD 8.18
Ptbv Ratio	0.82
Relative Volume	1.05x
Revenue	3,905,421,000x
Tax By Revenue	2.47x
Tax Rate	21.49%
Tr20y	169.07%
Tr6m	-22.93%
Volume	172,983

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

TPEX/1565 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+5.7%

$5.80 annual per share

Payout ratio

+136.0%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

-12.0%

1 consecutive years of growth

Total shareholder yield

+5.3%

Next ex-dividend date: 2025-08-25

Performance

TPEX/1565 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns TPEX/1565?

Insider, institutional, and short-interest positioning.

Institutional ownership

+13.5%

Share of float held by funds and institutions

Insider ownership

+6.1%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+0.4%

Negative means the company is buying back shares.

Technical

TPEX/1565 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

41.3

Neutral momentum band

Price vs 200-day MA

-19.3%

50/200-day relationship not available

Beta (5Y)

0.35

Less volatile than the market

Sharpe ratio

-2.11

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About TPEX/1565

Hub-level FAQ points readers to the deeper analysis pages.

What is the current tpex/1565 stock rating?

tpex/1565 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full tpex/1565 analysis?

The full report lives at /stocks/tpex/1565/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for tpex/1565?

The latest report frames tpex/1565 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the tpex/1565 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.